To evaluate the tolerability and safety of ONO-7475 monotherapy and combinations with
      ONO-4538 in patients with advanced or metastatic solid tumors

Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

ONO-7475

ONO-7475 + ONO-4538

Open-label, Uncontrolled, Dose-escalation Study of ONO-7475 Given as Monotherapy and Combinations With ONO-4538 in Patients With Advanced or Metastatic Solid Tumors

Assessment of the maximum plasma concentration of ONO-7475 both alone and in combination with ONO-4538

Assessment of the time to reach maximum observed plasma concentration of ONO-7475 both alone and in combination with ONO-4538

Assessment of the plasma area under the curve of ONO-7475 both alone and in combination with ONO-4538

Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?